L415-0557 Screening compound: 2,5-DIMETHYL-1-[6-(4-METHYLPIPERIDINO)-3-PYRIDYL]-N-(3-MORPHOLINOPROPYL)-1H-PYRROLE-3-CARBOXAMIDE

L415-0557 Screening compound: 2,5-DIMETHYL-1-[6-(4-METHYLPIPERIDINO)-3-PYRIDYL]-N-(3-MORPHOLINOPROPYL)-1H-PYRROLE-3-CARBOXAMIDE
L415-0557 Screening compound: 2,5-DIMETHYL-1-[6-(4-METHYLPIPERIDINO)-3-PYRIDYL]-N-(3-MORPHOLINOPROPYL)-1H-PYRROLE-3-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound L415-0557
2,5-DIMETHYL-1-[6-(4-METHYLPIPERIDINO)-3-PYRIDYL]-N-(3-MORPHOLINOPROPYL)-1H-PYRROLE-3-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L415-0557

Molecular Formula

C25H37N5O2 (C25 H37 N5 O2)

Compound Name

2,5-DIMETHYL-1-[6-(4-METHYLPIPERIDINO)-3-PYRIDYL]-N-(3-MORPHOLINOPROPYL)-1H-PYRROLE-3-CARBOXAMIDE

IUPAC name

n/a

SMILES

CC(CC1)CCN1c(cc1)ncc1-n(c(C)c1)c(C)c1C(NCCCN1CCOCC1)=O

InChI

InChI=1S/C25H37N5O2/c1-19-7-11-29(12-8-19)24-6-5-22(18-27-24)30-20(2)17-23(21(30)3)25(31)26-9-4-10-28-13-15-32-16-14-28/h5-6,17-19H,4,7-16H2,1-3H3,(H,26,31)

InChI Key

MQVMHRKILUPMIN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15126799

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

439.6

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.118

Distribution Coefficient, logD

2.730

Water Solubility, LogSw

-3.12

Polar Surface Area

51.103

Acid Dissociation Constant (pKa)

15.28

Base Dissociation Constant (pKb)

7.56

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

60.00

L415-0557 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L415-0557 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L415-0557?
Check Price and Availability of L415-0557, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L415-0557 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L415-0557
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L415-0557
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L415-0557 available by request